You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恩華藥業(002262.SZ)業績快報:2020年淨利升9.80%至7.28億元
格隆匯 02-26 17:19

格隆匯 2 月 26日丨恩華藥業(002262.SZ)披露2020年度業績快報,營業總收入33.61億元,同比下降18.99%;營業利潤8.56億元,同比增長11.07%;歸屬於上市公司股東的淨利潤7.28億元,同比增長9.80%;基本每股收益0.72元。

2020年度,公司面對新冠疫情的影響以及醫藥行業的不利環境和競爭壓力,公司緊緊圍繞“把握市場,搶抓機遇,提升實力,穩步發展”的指導思想,以“夯實基礎,細化管理,技術當先,質量保證”為經營方針,繼續以科技創新和加強內部管理為重點,外抓市場,內抓管理,不斷進行創新突破,確保公司可持續發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account